Device Trial Radar · NCT04798768
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
297
Actual
Start
Jul 20, 2021
Primary completion
May 6, 2024
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Mar 15, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The MODULAR ATP Clinical Study is designed to demonstrate safety, performance, and effectiveness of the Modular Cardiac Rhythm Management (mCRM) Therapy System.
Conditions
- Tachycardia, Ventricular
- Arrhythmia, Ventricular
Interventions
mCRM Therapy SystemDevice
Communication testing between S-ICD and LCP in 4 body postures as well as required electrical testing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Endpoint 1: Percentage of Subjects Without Major EMPOWER MPS System- or Procedure-Related Complications Through 6 MonthsTime frame: Implant through 6 Months Post-Implant
3 more outcomes with a free account
Locations
38 sites in 9 countries. Site status is shown where the registry gives one.
Banner University Medical Center Phoenix
Phoenix, Arizona
37 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.